CCR2 and neoplasm: In line with a functional involvement of alternatively activated myeloid cells in influencing tumor burden, the infiltration of pLKO.1 versus shTRAIL-R 3LL tumors was significantly decreased by shTRAIL-R in WT, but not in CCR2-deficient, mice (Figures 6D and 6E).